1. Treatment of 320 genotype 3 cirrhotic patients with 12 weeks Sofosbuvir/Velpatasvir with or without ribavirin: real life experience from Italy. (February 2019) Authors: Pasulo, L.; Gambato, M.; Spinetti, A.; D'Ambrosio, R.; Puoti, M.; Ciancio, A.; Di Marco, V.; Calvaruso, V.; Colombatto, P.; Brunetto, M.; Schiavini, M.; Fabris, P.; Sacchi, P.; Gulminetti, R.; Carolo, G.; Scotton, P.; Pozzan, C.; Vinci, M.; Viganò, M.; Lombardi, A. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗